Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)
Condition(s):Proliferative VitreoretinopathyLast Updated:September 2, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Proliferative VitreoretinopathyLast Updated:September 2, 2020Recruiting
Condition(s):Multiple SclerosisLast Updated:January 19, 2017Unknown status
Condition(s):Systemic Lupus Erythematosus (SLE); Repository Corticotropin InjectionLast Updated:September 13, 2019Withdrawn
Condition(s):SarcoidosisLast Updated:March 24, 2020Not yet recruiting
Condition(s):Dermatomyositis; Juvenile DermatomyositisLast Updated:January 22, 2020Recruiting
Condition(s):Rheumatoid ArthritisLast Updated:November 10, 2020Recruiting
Condition(s):UveitisLast Updated:September 27, 2018Unknown status
Condition(s):Membranous NephropathyLast Updated:April 9, 2020Recruiting
Condition(s):Dermatomyositis; PolymyositisLast Updated:September 1, 2017Completed
Condition(s):IgA Nephropathy; ProteinuriaLast Updated:April 5, 2017Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.